Abstract
The intention of this prospective study was to compare the diagnostic potential of technetium-99m sestamibi (MIBI) and a novel radiotracer,99mTc-Tetrofosmin (Tetro), for the assessment of primary nasopharyngeal carcinoma (NPC) and the differentiation of residual disease from post-therapy changes. A total of 38 patients underwent MIBI and Tetro single-photon emission tomography (SPET) imaging at initial presentation (n=22) or following therapy (n=16). The findings were correlated with computed tomography or magnetic resonance imaging (MRI) on a site-by-site basis. Tumour/background (Tm/Bkg) ratios were obtained on coronal sections. Biopsy (nine patients) and/or 12- to 24-month clinical follow-up data were available in the post-therapy group. All primary disease sites were accurately detected by both imaging studies. Although there was no statistical difference between the two imaging techniques in the detection of primary disease, MIBI was superior to Tetro in the detection of regional lymph node metastases (sensitivity: 95% vs 79%). Tetro and MIBI SPET were true-positive in all patients (n=7) with proven residual/recurrent diseuse. In nine patients who had no evidence of residual/recurrent tumour, MRI was false-positive in five while Tetro and MIBI SPET were false-positive in two and three patients, respectively. Tm/Bkg ratios were ≤1.7 in all false-positive cases except one. Tetro, MIBI and MRI had specificities of 78%, 67% and 44%, and accuracies of 87.5%, 81% and 69%, respectively. The results of Tetro and of MIBI SPET were rot statistically different from one another with regard to the prediction of residual/recurrent or metastatic NPC.
Similar content being viewed by others
References
Celai E, Olmi P, Chiavacci A, et al. Computed tomography in NPC. Part I. T stage conversion with CT staging. Part II. Impact on survival.Int J Radiat Oncol Biol Phys 1990; 19: 1171–1182.
Sham JST, Choy D. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma on local control and short-term survival.Head Neck 1991; 13: 298–310.
Teo P, Shiu W, Leung SF, Lee WY. Prognostic factors in nasopharyngeal carcinoma investigated by computer tomography — an analysis of 659 patients.Radiother Oncol 1992; 23: 79–93.
Withers HR, Peters LJ. Basic principles of radiotherapy: biological aspects of radiation therapy. In: Fletcher GH, ed.Textbook of radiotherapy, 3rd edn. Philadelphia: Lea and Febiger, 1980: 103–108.
Sham JST, Wei WI, Kwan WH, Chan CW, Kwong WK, Choy D. Nasopharyngeal carcinoma: pattern of tumor regression after radiotherapy.Cancer 1990; 65: 216–220.
Rege S, Maas A, Chaiken L, et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers.Cancer 1994; 73: 3047–3058.
Zeitouni AG, Yamamato YL, Black M, Gjedde A. Functional imaging of head and neck tumors using positron emission tomography.J Otolaryngol 1994; 23: 77–80.
Lindholm P, Leskinen-Kallio, Grenman R, et al. Evaluation of response to radiotherapy in head and neck cancer by positron emission tomography and [11C]methionine.Int J Radiat Oncol Phys 1995; 32: 787–794.
Leskinen-Kallio S, Lindholm P, Lopela M, et al. Imaging of head and neck tumors with positron emission tomography and [11C]methionine.Int J Radiat Oncol Biol Phys 1995; 30: 1195–1199.
Marano I, Brunetti A, Covella M, et al. Magnetic resonance in the diagnosis and follow-up of soft tissue sarcomas.Radiol Med 1992; 84: 15–21.
Franc J, Vanel D, Schwaab G, Eschwege F, Micheau C. Interet de l'imagerie par resonnance magnetique dans le bilan initial et la surveillance des carcinomes indifferencies de typr nasopharynge (UCNT).Rev Im Med 1991; 3: 181–185.
Ramannah L, Waxman AD, Binney G, Waxman S, Mirra J, Rosen G. Tl-201 scintigraphy in bone sarcoma: comparison with Ga-67 and Tc-99m MDP in the evaluation of chemotherapeutic response.J Nucl Med 1990; 31: 567–571.
Abdel-Dayem H, Scott AM, Macapinlac HA, El-Gazzar AH, Larson SM. Role of Tl-201 chloride and Tc-99m-sestamibi in tumor imaging. In: Freeman LM, ed.Nuclear medicine annual. New York: Raven Press; 1994: 181–234.
Kostakoglu L, Panicek DM, Divgi CR, Botet J, Healey J, Larson SM, Abdel-Dayem HM. Comparative study with thallium-201 chloride, MRI, angiography in patients with soft tissue sarcomas following treatment.Eur J Nucl Med 1995; 22: 1232–1237.
Rambaldi PF, Mansi L, Procaccini D, Di Gregorio F, Del Vecchio E. Breast cancer detection with Tc-99m tetrofosmin.Clin Nucl Med 1995; 20: 703–705.
Gregor RT, Valdes-Olmos R, Koops W, Balm AJ, Hilgers FJ, Hoefnagel CA. Preliminary experience with thallous chloride T1 201-labeled single-photon emission computed tomography scanning in head and neck cancer.Arch Otolaryngol Head Neck Surg 1996; 122: 509–514.
Kao CH, Wang SJ, Lin WY, Hsu CY, Liao SQ, Yeh SH. Detection of nasopharyngeal carcinoma using99mTc-methoxyisobutylisonitrile SPECT.Nucl Med Commun 1993; 14: 41–46.
Togawa T, Yui N, Kinoshita F, Shimada F, Omua K, Takemiya S. Visualization of nasopharyngeal carcinoma with Tl-201 chloride and three-head rotating gamma camera SPECT system.Ann Nucl Med 1993: 7: 105–113.
Kostakoglu L, Uysal U, Özyar E, et al. Pre- and post-therapy Tl-201 and Tc-99m-sestamibi SPECT in patients with nasopharyngeal carcinoma.J Nucl Med 1996; 37: 1956–1962.
Kelly ID, Forster AM, Higley B, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging.J Nucl Med 1993; 34: 222–227.
Rigo P, Leclercq B, Itti R, Lahiri A, Braat S. Technetium-99m-myocardial imaging: a comparison with thallium-201 and angiography.J Nucl Med 1994; 35: 587–593.
World Health Organization. In: Histological typing of upper respiratory tract tumors.International Histological Classification of Tumors, no 19. Geneva: World Health Organization, 1978; 32–33.
International Nasopharnx Cancer Study Group; VUMCA I Trial. Preliminary results of a randomized tail comparing neoadjuvant chemotherapy (ciplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival.Int J Radiat Oncol Biol Phys 1996; 35: 463–469.
Altun M, Fandi A, Dupuis O, et al. Undifferentiated nasopharyngeal cancer (UCNT). Current diagnostic and therapeutic aspects.Int J Radiat Oncol Biol Phys 1995; 32: 859–877.
Mendenhall WM, Million RR, Maneuso AA, Stringer SP. Nasopharynx. In: Millon RR, Cassisi NJ, eds.Management of head and neck cancer. A multidisciplinary approach, 2nd end. Philadelphia: Lippincott; 1994.
Arbab AS, Koizumi K, Toyama K, Tsutomu A. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines.J Nucl Med 1996; 37: 1551–1556.
Sobel ME. Metastases suppressor genes.J Natl Cancer Inst 1990; 82: 267–276.
Taifu L. Trends in the clinical management of NPC.Int J Radiat Oncol Biol Phys 1992; 23: 469–471.
Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence.Circulation 1990; 82: 1826–1838.
Carvalho PA, Chiu ML, Kronauge JF, et al. Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts.J Nucl Med 1992; 33: 1516–1521.
Piwnica-Worms D, Chiu ML, Budding M, et al. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.Cancer Res 1993; 53: 977–984.
Dillon WP. The pharnyx and oral cavity. In: Som PM, Bergeron RT, eds.Head and neck imaging, 2nd edn. St. Louis, Mo.: Mosby-Year Book; 1991: 407–465.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kostakoglu, L., Uysal, U., Özyar, E. et al. A comparative study of technetium-99m sestamibi and technetium-99m tetrofosmin single-photon tomography in the detection of nasopharyngeal carcinoma. Eur J Nucl Med 24, 621–628 (1997). https://doi.org/10.1007/BF00841399
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00841399